PubMed Health⌕ Search

Biomedical subjects

H Sakamoto

Publications and source records attributed to H Sakamoto.

At least 775 records · Page 43Linked to original sources

Technetium-99m serum albumin measurement of gastrointestinal protein loss in a subtotal gastrectomy patient with giant hypertrophic gastritis.

Gastrointestinal protein loss was measured using Tc-99m labeled human serum albumin in a patient with giant hypertrophic gastritis. Gastric secretion was aspirated via a nasogastric tube and measured for radioactivity after intravenous injection of Tc-99m albumin. Assessment of radioactivity of the collected gastric secretion yielded a total radiocount of 98.7 kilocounts per minute within 6 hours, which is equivalent to 1.1% of the total dose. Therefore, at least 1.1% of the circulating albumin was excreted into the gastric cavity within 6 hours, and, since simultaneous abdominal imaging did not demonstrate obvious accumulation of tracer in the gastrointestinal tract, protein loss was thought to be due to giant gastric rugae of the resected stomach. It was concluded that Tc-99m albumin is a valuable means for detection of the site of protein loss in patients with protein-losing gastroenteropathy. This method has several advantages in the clinical setting; it is less time consuming, easy to perform, and provides quantitative and qualitative assessment of protein loss.

Female↗

Insulin specific binding sites in the myometrium of pregnant rats.

Insulin (INS) specific binding sites were detected in the myometrium of pregnant rats. The apparent equilibrium dissociation constants for the higher and lower affinity INS binding components were 0.01 X 10(-9) M and 2.5 X 10(-9) M, respectively. During the latter half of pregnancy INS binding increased gradually and peaked on the day of parturition (159.9 +/- 19.8, 196.3 +/- 24.6, 254.7 +/- 36.8, and 272.6 +/- 29.1 and femtomolars per mg protein, mean +/- SEM on days 15, 20, 21, and 22 of gestation, respectively). The pattern of increased INS binding paralleled the prepartum increase in myometrial cell nuclear estrogen receptors as well as myometrial glycogen levels. In contrast, low INS binding was associated with elevated cell nuclear progestin receptor levels, on day 15 and immediately postpartum. These results suggest that, during the latter half of pregnancy, myometrial INS binding capacity and glycogen concentration gradually increase. Since INS receptor levels begin to increase in parallel with increasing nuclear estrogen receptors, INS receptor synthesis may be under estrogen control.

Animals↗

Down-regulation of central serotonin S2 receptors after repeated treatment with quinupramine in rats.

The present studies were undertaken to determine whether the repeated administration of quinupramine caused down- or up-regulation of beta-, alpha 2-adrenergic, serotonin S2, imipramine and muscarinic cholinergic receptors, as had been demonstrated for tricyclic and atypical antidepressant drugs. Quinupramine administered at 10 mg/kg (p.o.) twice daily for 10 days caused a down-regulation of serotonin S2 receptors in the frontal cortex of the rat as determined by [3H]ketanserin binding. However, quinupramine did not alter the binding populations of beta-adrenergic, muscarinic cholinergic and alpha 2-adrenergic receptors in the rat brain as determined by the Scatchard analysis of the [3H]ligand binding data. Differing from quinupramine, imipramine caused down-regulation of beta-adrenergic and serotonin S2 receptor bindings, and it caused slight but significant up-regulation of muscarinic cholinergic receptor bindings. These results show that the antidepressant activity of quinupramine is associated with the central serotonin system, but not with the beta-adrenergic system. Accordingly, quinupramine, chemically one of the typical tricyclic antidepressant drugs, seems to be pharmacologically one of the atypical antidepressant drugs, and it was suggested that the central serotonin system plays an important role in the antidepressant activity of quinupramine.

Animals↗

Effects of quinupramine on the central monoamine uptake systems and involvement of pharmacokinetics in its pharmacological activities.

The effects of a new tricyclic antidepressant drug, quinupramine, on the monoamine uptake of rat brain homogenate preparations were studied in comparison with imipramine. Pharmacokinetic studies on quinupramine and imipramine in plasma and brain were also performed in rats after a single oral administration. Quinupramine had few effects on the noradrenaline and serotonin uptake both in in vitro and ex vivo models. After the administration of [3H]quinupramine, the unchanged drug was estimated as 60-75% of the total radioactivity in the cerebral cortex. Imipramine and desipramine preferentially inhibited the uptake of serotonin and noradrenaline, respectively, in vitro. After the administration, imipramine showed a marked inhibitory effect on noradrenaline uptake. A considerable amount of desipramine but not imipramine could be detected in the brain and plasma after the administration of [3H]imipramine. These results demonstrate that 1) the antidepressant activity of quinupramine cannot be attributed to inhibition of monoamine uptake, 2) unchanged quinupramine penetrates into the CNS and affects some of the processes of neurotransmission and 3) the pharmacological activities of imipramine, when administered orally, may be attributed to desipramine, the metabolite formed.

Animals↗

Binding characteristics of [3H]quinupramine to rat brain membrane fractions.

The binding characteristics of [3H]quinupramine to rat brain membrane fractions were studied. The specific binding of [3H]quinupramine to rat brain membrane fractions was stable, reversible and saturable. Scatchard analysis of the data from saturation experiments indicated that the specific binding was a single population with an affinity (KD) of 3.04 nM, a maximal binding site number (Bmax) of 714 fmol/mg protein, and a Hill coefficient (nH) of 1.08. Compounds known to inhibit muscarinic cholinergic receptors such as atropine and quinuclidinyl benzilate were the most potent competitors of [3H]quinupramine binding. When the drug potencies in inhibiting [3H]quinupramine binding were tested in the presence of 10 nM atropine, mianserin was the most potent competitor. Studies of the subcellular fractions showed that there was an enrichment of [3H]quinupramine binding sites in the synaptosome fraction. The regional distribution study revealed the highest densities of binding sites in the cerebral cortex and the lowest in the cerebellum. Thus, the specific binding of [3H]quinupramine observed here can be accounted for by both muscarinic cholinergic and serotonin S2 receptors.

Animals↗

A study of cytoplasmic and nuclear estrogen and progestin receptors in gynecologic neoplasms.

A rapid method for simultaneous preparation of cytosol and nuclear estrogen (E) and progestin (P) receptors and their in vitro determination is described. The method was applied to several uterine or ovarian surgical specimens to evaluate their steroid hormone "dependence". The results suggest that low cytoplasmic E receptor levels (ERc) are associated with higher nuclear E receptor (ERn) levels but no apparent correlation was observed between PRc and ERn levels. The method appeared to be suitable for screening steroid hormone receptor content in tumor tissues and may provide better estimation of steroid dependence since both cytoplasmic and nuclear compartments can be studied simultaneously.

Adult↗

[Effects of uterine contraction and a beta-stimulant on placental and fetal brain blood flow in correlation with fetal heart rate changes].

The effects of uterine contraction on placental and fetal brain blood flow in correlation with fetal heart rate change and also beta-stimulant on placental and fetal brain blood flow during late deceleration were studied in late pregnant rabbits. We determined the fetal heart rate (FHR) and placental and fetal brain blood flow by a thermocouple method under urethane anesthesia. Fetuses exposed to a more than 30% decrease in placental blood flow by uterine contraction developed more than 20% bradycardia and also a significant decrease in fetal brain blood flow. There are a significant relationship between the decrease in FHR and fetal brain blood flow. beta-stimulant administered to the mother suffering from already severely hypoxic fetal bradycardia increased FHR in accordance with the increase in the placental blood flow and moreover there was recovery from decreased fetal brain blood flow.

Adrenergic beta-Agonists↗

Identification of transforming genes as hst in DNA samples from two human hepatocellular carcinomas.

In a DNA-mediated transfection assay using NIH3T3 cells, the DNAs from two out of twelve human hepatocellular carcinomas gave transformants. The transforming gene was identified as hst, which was originally found in DNAs from stomach cancers and a noncancerous portion of stomach mucosa, the putative product being a growth factor. Transcripts were not detected in the original HCC 1 and HCC2 upon Northern blot analysis. The possible mechanisms involved in the hst gene activation are discussed.

Carcinoma, Hepatocellular↗

Activation of N-ras gene in a rat hepatocellular carcinoma induced by dibutylnitrosamine and butylated hydroxytoluene.

DNA samples from eighteen rat hepatocellular carcinomas, including those induced by oral administration of dibutylnitrosamine (DBN) with butylated hydroxytoluene (BHT), or DBN with butylated hydroxyanisole (BHA), have been tested for the presence of transforming activity by transfection assay with NIH3T3 cells. Of the eighteen samples, only one from a tumor induced by DBN and BHT gave transformants. the activated oncogene was identified as rat N-ras by Southern blot analysis.

Animals↗

[Effects of RU38486, an antiprogesterone agent, on endometrium, fertilized ovum and serum sex steroid levels in rats].

Effects of antiprogesterone RU38486 were studied in rats. The synthetic compound effectively (100%) inhibited implantation when administered on day 2 as well as on day 4 postconception (2.5mg/kg, in glycerol). This treatment, however, did not alter circulating estradiol and progesterone levels. Fertilized ovum yielded on day 4 from the uterine cavity showed normal morphology including adequate progress in cell division. A light microscopic study of the endometrium showed decreased cytoplasmic vacuole formation but estrogenic effects were apparently preserved. These data suggest that administration of RU38486 immediately after conception could successfully prevent implantation without altering early luteotropic functions in rats. Also the high dose of the compound was found to have no significant toxic effects on fertilized ovum, indicating that the anticonceptional action of RU38486 mainly functions at the uterine endometrial level.

Animals↗

[Bone disorder in long-term survival after gastrectomy with reference to bone mineral content].

To investigate post-gastrectomy metabolic bone disorder, the radial bone mineral content (BMC) was measured with 125I-photon absorptiometry in 131 long-term survivors, the postoperative periods ranged 3 to 30 years. Sixty-eight patients (52 per cent) showed abnormally low BMC levels compared with healthy controls. The 43 patients with total gastrectomy manifested a higher incidence of decreased BMC levels than did the other 88 patients with partial gastrectomy. In females, patients subjected to the Billroth II procedure manifested low BMC values. The extent of the decline in BMC was much higher in females than in males, and higher in totally gastrectomized patients than in partial gastrectomy group. At more than 10 years postoperatively many patients manifested markedly low BMC levels; in totally gastrectomized patients this finding was made at less than 5 years postoperatively. A significant correlation was found between the extent of the decreased BMC levels and the postoperative periods. Of the patients with decreased BMC values, 30 per cent of them gave histories of osseous symptom after gastrectomy, however, 70 per cent of patients were asymptomatic. Based on the results, in long-term survival treated by total or partial gastrectomy, many patients present an osteopenic status, however, the number of those with clinically manifested bone disease such as osteomalacia may be low.

Age Factors↗

[A novel transforming gene from human stomach cancers].

We have identified a novel transforming gene, hst, from a human stomach cancer, and the results of our studies on hst are reviewed. From a total of 26 patients with stomach cancer, DNAs from 21 of their stomach cancers, 16 metastatic lymph node tumors from stomach cancers and 21 non-cancerous stomach mucosae, were assayed for their transforming activity to NIH3T3 cells. Three samples of DNA were positive; one was from a primary stomach cancer, the second from a non-cancerous portion of the same patient's stomach mucosa, and the third from a lymph node metastasis stomach cancer from a different patient. A portion of the transforming gene and near full-length cDNA for this gene was cloned. From the results of cDNA sequence and Southern blot analyses, this transforming gene was shown to have no homology with the oncogene reported previously. We applied the term, hst (human stomach cancer), to this novel transforming gene. The hst gene was found to be responsible for acquisition of transforming activity of all the three different samples of DNAs.

Cloning, Molecular↗

[Gap junction formation in the myometrial muscle cells of ovariectomized mid-pregnant rats during premature labor induced by estradiol].

In order to obtain a better understanding of gap junction (GJ) formation in the myometrial muscle cells of rats during the time of premature delivery, the myometrial GJs and nuclear estradiol receptor (nE2R) levels, as well as serum estradiol (E2) and progesterone (P) levels were simultaneously determined in mid-pregnant ovariectomized (OVX) rats both with and without E2 administration. Artificial premature deliveries were not induced in either the rats which were OVX on day 15 of gestation with the E2 treatment, or which were OVX on day 16 with the vehicle treatment. However, there were significant decreases in serum P and significant increases in the number of myometrial GIs in these rats compared to the levels of the non-OVX pregnant rats treated with the vehicle. These results suggest that serum P withdrawal and GJ formation are not sufficient to induce premature delivery, and that other factors are involved. Artificial premature delivery was induced in the rats which were OVX on day 16 with the E2 treatment. They were given 2.5 micrograms E2 twice daily, for two days. A significant decrease in serum P, a marked increase in the number of GJ and a significant correlation between the myometrial GJs and serum E2 levels were found in both the "premature" delivery rats and the "prior to" delivery rats. A significant difference between the nE2R levels of the two groups was found, however. These profiles closely resembled those of the full-term rats during spontaneous delivery as we reported earlier.

Animals↗

A study of anti-progestational compound RU38486 action on the estrogen-induced enlargement of the rat pituitary gland.

Long term administration of estradiol to intact and ovariectomized female rats caused enlargement of the pituitary gland. This process was partially antagonized in intact animals when antiprogestational compound RU38486 was given concomitantly. In ovariectomized rats, however, this effect of RU38486 was not apparent. Since administration of the compound to ovariectomized animals did not alter estrogen-receptor translocation or estrogen induced hypervascularity in the pituitary gland, this inhibitory effect of RU38486 seems not to be exerted through estrogen-receptor binding antagonism but rather due to a progesterone receptor blockade at the hypothalamic-pituitary axis.

Adenoma↗